Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
INACTIVE COMPANY
 
My Lists

POINT Biomedical

887L Industrial Road
San Carlos, CA 94070
USA
(650)-596-1400
Website Company Summary Management Team
Team

Management: Thomas L Feldman (President/CEO)Madeline Miller (VP Clinical Operations);  Malcolm Farnsworth (CFO)
Outside board: Paul Goddard (Elan Pharmaceuticals President/CEO)Fred Dotzler (Medicus Venture Partners)Alan Kittner (INVESCO Private Capital General Partner)Ronald Lennox (CHL Medical General Partner)Arda Minocherhomjee (William Blair Capital Partners Managing Director)L James Strand (Institutional Venture Partners Venture Partner)
Company

Business description: POINT Biomedical is a privately held pharmaceutical company, founded to pursue technologies related to imaging and drug delivery. POINT's core technology is based upon an ultrasonically responsive two-layer, biodegradable microsphere or biSphere™. One of the most important features of this technology is the ability to noninvasively trigger the biSpheres to release their contents at sites within the body using externally generated pulses of ultrasound. From this basic platform, POINT is developing a pipeline of products that leverage the unique properties of the biSphere technology in the areas of imaging and therapeutics. POINT has initially focused development of this platform on the assessment of tissue specific blood flow. The lead product, CARDIOsphere™, is a pharmaceutical agent that will enable cardiologists to perform myocardial perfusion imaging studies in the office setting using ultrasound rather than more expensive and cumbersome nuclear (or radioisotope) techniques.
Customers include: internists;  radiologist;  urologists
Capital

Rounds: 8
Recent fundings: Jan 2008   Jul 2007
Capital raised: 114.7M
Last Round: 25.0M
Ownership: Private  
VCs include: CHL Medical PartnersDe Novo VenturesFrazierAndCompanyInstitutional Venture PartnersInvesco Private CapitalMedicus Venture PartnersPalo Alto InvestorsSaints CapitalSprout GroupSR One Limited;  Anvers L.P., Fininvest, Oakwood Medical Investors;  William Blair Capital Partners VII
Corporate investors: GE Capital;  General Electric Capital Corporation

Last Tweets


 

Last Mentions


Overview
Record updated: Jan 2008
Sector: Medical
Year Founded: 1996
Rounds: 8
Recent fundings: Jan 2008   Jul 2007
Capital raised: 114.7M
Last Round: 25.0M
Ownership: Private